Hypereosinophilic Syndromes
Also known as: HES - Hypereosinophilic Syndrome / Hypereosinophilic Syndrome (HES) / Hyper Eosinophilic Syndrome / Hypereosinophilic Syndrome / Hypereosinophilic syndrome [HES], unspecified / Hypereosinophilic syndrome [HES] / Hypereosinophilic syndrome (morphologic abnormality) / Hypereosinophilic syndrome (disorder) / Idiopathic hypereosinophilic syndrome (morphologic abnormality) / Idiopathic hypereosinophilic syndrome (disorder) / Idiopathic Hypereosinophilic Syndrome
Drug | Drug Name | Drug Description |
---|---|---|
DB01005 | Hydroxyurea | An antimetabolite used to treat sickle cell anemia crisis, resistant chronic myeloid leukemia, and Locally advanced squamous cell carcinomas of the head and neck (excluding the lip). |
DB00619 | Imatinib | A tyrosine kinase inhibitor used to treat a number of leukemias, myelodysplastic/myeloproliferative disease, systemic mastocytosis, hypereosinophilic syndrome, dermatofibrosarcoma protuberans, and gastrointestinal stromal tumors. |
DB06612 | Mepolizumab | A fully-humanized monoclonal IgG1 kappa anti-IL-5 antibody used in conjunction with other therapies to treat severe asthma, eosinophilic granulomatosis with polyangiitis, and hypereosinophilic syndrome. |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB06612 | Mepolizumab | 1 / 2 | Completed | 1 |
DB04868 | Nilotinib | 1 / 2 | Completed | 1 |
DB01254 | Dasatinib | 2 | Completed | 1 |
DB15130 | Dexpramipexole | 2 | Unknown Status | 1 |
DB00619 | Imatinib | 2 | Completed | 2 |
DB00619 | Imatinib | 2 | Recruiting | 1 |
DB00619 | Imatinib | 2 | Terminated | 2 |
DB00619 | Imatinib | 2 | Unknown Status | 1 |
DB06602 | Reslizumab | 2 | Completed | 1 |
DB08877 | Ruxolitinib | 2 | Recruiting | 2 |
DB12023 | Benralizumab | 3 | Recruiting | 1 |
DB06612 | Mepolizumab | 3 | Completed | 3 |
DB06612 | Mepolizumab | 3 | Recruiting | 1 |
DB06612 | Mepolizumab | 3 | Terminated | 1 |
DB00860 | Prednisolone | 3 | Completed | 1 |
DB00635 | Prednisone | 3 | Completed | 1 |
DB00635 | Prednisone | 4 | Completed | 1 |
DB00619 | Imatinib | Not Available | Completed | 1 |
DB06612 | Mepolizumab | Not Available | No Longer Available | 1 |
DB04868 | Nilotinib | Not Available | No Longer Available | 1 |